Search Results 701-710 of 21427 for anti-TNF drugs

1. Terbutaline (Subcutaneous Route) Precautions - Mayo Clinic

   Drugs and Supplements · Terbutaline (Subcutaneous ... You may also be taking an anti-inflammatory ... Drugs & Supplements; Terbutaline (Subcutaneous ...

2. Chlorambucil (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Upadacitinib (Oral Route) Precautions - Mayo Clinic

   Use an effective form of birth control to keep from getting pregnant during treatment and for at least 4 weeks after the last dose. If you think you have become ...

4. Triamterene And Hydrochlorothiazide (Oral Route) Description and Brand Names - Mayo Clinic

   Triamterene and hydrochlorothiazide combination is used alone or with other medicines to treat water retention (edema) or high blood pressure (hypertension).

5. Progestin Contraceptives (Oral Route, Parenteral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aygestin; Camila; Errin; Jolivette; Lyza ...

6. Escitalopram (Oral Route) Precautions - Mayo Clinic

   These may be symptoms of a serious condition called serotonin syndrome. The risk may be higher if you or your child also take certain other medicines that ...

7. Tretinoin (Topical Route) Precautions - Mayo Clinic

   Precautions · For patients using tretinoin for the treatment of acne: Regular use of water-based creams or lotions helps to reduce skin irritation or dryness ...

8. Acetaminophen And Codeine (Oral Route) Description and Brand Names - Mayo Clinic

   Codeine belongs to the group of medicines called narcotic analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain. When codeine ...

9. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

   A phase 1 study finds low incidence of severe side effects and high response rate for ide-cel, an anti-BCMA CAR-T cell therapy for relapsed or refractory ...

10. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Drugs used in chemotherapy, such as capecitabine ... anti-EGFR antibody (if tumor is RAS wild-type) ... TNF] agents) =< 14 days prior to randomization ...